adenosine has been researched along with Brain Infarction in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grove, EL; Hvas, AM; Kristensen, SD; Larsen, ML; Pedersen, OH | 1 |
| Chen, JF; Duan, W; Gui, L; Li, C; Tian, H; Zheng, J; Zhu, J | 1 |
| Cho, GS; Choi, IY; Choi, WJ; Hwang, S; Jeong, LS; Ju, C; Kim, WK; Lee, HW; Lee, JC | 1 |
| Chen, S; Dong, H; Hou, L; Hu, S; Wang, S; Xiong, L; Zhang, H; Zhang, J | 1 |
| Cipriani, S; Gianfriddo, M; Melani, A; Pedata, F; Turchi, D; Vannucchi, MG | 1 |
| Chen, GJ; Chou, J; Harvey, BK; Shen, H; Victor, A; Wang, Y | 1 |
| Abbracchio, MP; Cattabeni, F | 1 |
7 other study(ies) available for adenosine and Brain Infarction
| Article | Year |
|---|---|
Recurrent Cardiovascular Events Despite Antiplatelet Therapy in a Patient with Polycythemia Vera and Accelerated Platelet Turnover.
Topics: Adenosine; Brain Infarction; Clopidogrel; Drug Therapy, Combination; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Polycythemia Vera; Purinergic P2Y Receptor Antagonists; Secondary Prevention; Thrombocytosis; Ticagrelor; Ticlopidine | 2017 |
Adenosine A 2A receptor deficiency reduces striatal glutamate outflow and attenuates brain injury induced by transient focal cerebral ischemia in mice.
Topics: Adenosine; Animals; Brain Chemistry; Brain Infarction; Brain Ischemia; Corpus Striatum; Disease Models, Animal; Down-Regulation; Extracellular Fluid; Gene Expression Regulation; Genetic Predisposition to Disease; Glutamic Acid; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Receptor, Adenosine A2A; Up-Regulation | 2009 |
A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Brain Infarction; Brain Injuries; Brain Ischemia; Cell Movement; Chemokine CCL2; Glucose; Inflammation; Interleukin-1beta; Lipopolysaccharides; Male; Microglia; Monocytes; N-Methylaspartate; Protein Transport; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; rho GTP-Binding Proteins; Thionucleosides; Tumor Necrosis Factor-alpha | 2011 |
Noninvasive limb remote ischemic preconditioning contributes neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal cerebral ischemia in rats.
Topics: Adenosine; Analysis of Variance; Animals; Brain Infarction; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Extremities; Glutathione; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Ischemic Preconditioning; Lipid Peroxidation; Male; Nervous System Diseases; Neuroprotective Agents; Nitrites; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Severity of Illness Index; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Xanthines | 2012 |
ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Brain Infarction; Brain Ischemia; Corpus Striatum; Disease Models, Animal; Enzyme Inhibitors; Extracellular Fluid; Infarction, Middle Cerebral Artery; Male; Microdialysis; Movement Disorders; Rats; Rats, Wistar; Receptors, Purinergic P2; Up-Regulation | 2005 |
Activation of adenosine A3 receptors reduces ischemic brain injury in rodents.
Topics: Adenosine; Analysis of Variance; Animals; Blood Gas Analysis; Blood Pressure; Brain Infarction; Cell Survival; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Activation; Female; Hypoxia-Ischemia, Brain; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pregnancy; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A3; Tetrazolium Salts | 2006 |
Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
Topics: Adenosine; Animals; Astrocytes; Brain Infarction; Brain Ischemia; Cell Death; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Triazoles | 1999 |